Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Regulation of Multidrug Resistance in Endothelial Cells of the Fetal Blood-brain Barrier

FY 2009-10

Summary
Targeting of drugs in order to treat disorders of the brain has proven to be a rather difficult task. The few pharmaceuticals that in fact do cross the barrier between the blood and the brain are often pumped out of the brain by proteins known as "multidrug resistance transporters". Each of these drug transporters keep out a wide range of chemical compounds, which include a number of toxins, but also chemotherapeutics and important natural compounds produced in the body. The purpose of these drug transporters is both to protect the brain and regulate what gets in and what gets out. However, in early fetal development, this blood-brain barrier (bbb) (and its associated drug transporters) is not fully formed, which leaves the developing fetus susceptible to harmful compounds that could possibly enter from maternal circulation. Thus, it is critical that we understand the process by which the bbb develops to aid in the development of strategies to protect the fetus during susceptible periods. A class of steroids produced inside the body, known as "glucocorticoids" are thought to be important in the development of the bbb. Also, synthetic glucocorticoids are often given to pregnant women who are at risk of premature delivery (10% of pregnancies) and this treatment may greatly affect the development of the fetal bbb. Infection during pregnancy (which occurs very commonly) releases chemicals into the blood (called "cytokines"), which also seem to have strong effects on drug transporter function. None have investigated the effects of glucocorticoids and cytokines on fetal bbb development. Thus, we propose to investigate the regulation of drug transporters and bbb development using cell models and successively more complex models thereafter (i.e. animal models). A better understanding of how the bbb develops will contribute greatly to current knowledge in the field and has implications for all types of brain disorder research (i.e. cancer, stroke, etc.).
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
206144
Name
Iqbal Majid
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Regulation of Multidrug Resistance in Endothelial Cells of the Fetal Blood-brain Barrier
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Blood-Brain Barrier; Cytokines; Development; Glucocorticoids; Infection; Multidrug Resistance; Ssri; Steroids
Abstract
Targeting of drugs in order to treat disorders of the brain has proven to be a rather difficult task. The few pharmaceuticals that in fact do cross the barrier between the blood and the brain are often pumped out of the brain by proteins known as "multidrug resistance transporters". Each of these drug transporters keep out a wide range of chemical compounds, which include a number of toxins, but also chemotherapeutics and important natural compounds produced in the body. The purpose of these drug transporters is both to protect the brain and regulate what gets in and what gets out. However, in early fetal development, this blood-brain barrier (bbb) (and its associated drug transporters) is not fully formed, which leaves the developing fetus susceptible to harmful compounds that could possibly enter from maternal circulation. Thus, it is critical that we understand the process by which the bbb develops to aid in the development of strategies to protect the fetus during susceptible periods. A class of steroids produced inside the body, known as "glucocorticoids" are thought to be important in the development of the bbb. Also, synthetic glucocorticoids are often given to pregnant women who are at risk of premature delivery (10% of pregnancies) and this treatment may greatly affect the development of the fetal bbb. Infection during pregnancy (which occurs very commonly) releases chemicals into the blood (called "cytokines"), which also seem to have strong effects on drug transporter function. None have investigated the effects of glucocorticoids and cytokines on fetal bbb development. Thus, we propose to investigate the regulation of drug transporters and bbb development using cell models and successively more complex models thereafter (i.e. animal models). A better understanding of how the bbb develops will contribute greatly to current knowledge in the field and has implications for all types of brain disorder research (i.e. cancer, stroke, etc.).
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Iqbal, Majid
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~